Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Putaala, J; Martinez-Majander, N; Saeed, S; Yesilot, N; Jäkälä, P; Nerg, O; Tsivgoulis, G; Numminen, H; Gordin, D; von Sarnowski, B; Waje-Andreassen, U; Ylikotila, P; Roine, RO; Zedde, M; Huhtakangas, J; Fonseca, C; Redfors, P; de Leeuw, FE; Pezzini, A; Kõrv, J; Schneider, S; Tanislav, C; Enzinger, C; Jatuzis, D; Siegerink, B; Martínez-Sánchez, P; Grau, AJ; Palm, F; Groop, PH; Lanthier, S; Ten Cate, H; Pussinen, P; Paju, S; Sinisalo, J; Lehto, M; Lindgren, A; Ferro, J; Kittner, S; Fazekas, F; Gerdts, E; Tatlisumak, T.
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design.
Eur Stroke J. 2017; 2(2): 116-125. [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG


Autor/innen der Med Uni Graz:
Enzinger Christian
Fazekas Franz

Dimensions Citations:

Plum Analytics:
Number of Figures: 1
Worldwide, about 1.3 million annual ischaemic strokes (IS) occur in adults aged <50 years. Of these early-onset strokes, up to 50% can be regarded as cryptogenic or associated with conditions with poorly documented causality like patent foramen ovale and coagulopathies. (1) Investigate transient triggers and clinical/sub-clinical chronic risk factors associated with cryptogenic IS in the young; (2) use cardiac imaging methods exceeding state-of-the-art to reveal novel sources for embolism; (3) search for covert thrombosis and haemostasis abnormalities; (4) discover new disease pathways using next-generation sequencing and RNA gene expression studies; (5) determine patient prognosis by use of phenotypic and genetic data; and (6) adapt systems medicine approach to investigate complex risk-factor interactions. Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome (SECRETO; NCT01934725) is a prospective multi-centre case-control study enrolling patients aged 18-49 years hospitalised due to first-ever imaging-proven IS of undetermined etiology. Patients are examined according to a standardised protocol and followed up for 10 years. Patients are 1:1 age- and sex-matched to stroke-free controls. Key study elements include centralised reading of echocardiography, electrocardiography, and neurovascular imaging, as well as blood samples for genetic, gene-expression, thrombosis and haemostasis and biomarker analysis. We aim to have 600 patient-control pairs enrolled by the end of 2018. SECRETO is aiming to establish novel mechanisms and prognosis of cryptogenic IS in the young and will provide new directions for therapy development for these patients. First results are anticipated in 2019.

© Med Uni Graz Impressum